MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
2017-01-01 Zanotti, L; Romani, C; Tassone, L; Todeschini, P; Tassi, Ra; Bandiera, E; Damia, G; Ricci, F; Ardighieri, L; Calza, S; Marchini, S; Beltrame, L; Tognon, G; D'Incalci, M; Pecorelli, S; Sartori, E; Odicino, F; Ravaggi, A; Bignotti, E
RHPS4 telomere-interactive molecule: An active antitumoral agent with a high therapeutic index and a favorable integration with camptothecin in preclinical models of solid tumors
2007-01-01 Leonetti, C; Scarsella, M; Rizzo, A; Salvati, E; D'Incalci, M; Stevens, Mfg; Stoppacciaro, A; Stoppacciaro, A; Gilson, E; Zupi, G; Biroccio, A
Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters
2005-01-01 Minuzzo, M; Ceribelli, M; Pitarque-Marti, Ma; Borrelli, S; Erba, E; Disilvio, A; D'Incalci, M; Mantovani, R
Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors
2015-01-01 Vazquez, R; Astorgues-Xerri, L; Bekradda, M; Gormley, J; Buick, R; Kerr, P; Cvitkovic, E; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me
A Review of Trabectedin (ET-743): A Unique Mechanism of Action
2010-01-01 D'Incalci, M; Galmarini, Cm
In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin
1996-01-01 Belvedere, G; Imperatori, L; Damia, G; Tagliabue, G; Meijer, C; Devries, Ege; D'Incalci, M
The atypical retinoid ST1926 acts as a strong pro-apoptotic agent in human neuroblastoma
2005-01-01 Di Francesco, Am; Meco, D; Barone, G; Torella, A; Pisano, C; Vesci, L; Carminati, P; D'Incalci, M; Riccardi, R
Synthesis of Fluorescent PMMA-Based Nanoparticles
2013-01-01 Dossi, M; Ferrari, R; Dragoni, L; Martignoni, C; Gaetani, P; D'Incalci, M; Morbidelli, M; Moscatelli, D
Differences in cyclin B1 expression in cells blocked in the G2M phase after treatment with anticancer agent. New three-parametric flow cytometric analysis
1997-01-01 Faretta, M; Bergamaschi, D; Ronzoni, S; D'Incalci, M; Erba, E
Evaluation of the hematotoxic potential of methoxymorpholinyl-doxorubicin (MMDX) metabolites in patients plasma by clonogenic assays on hemopoietic progenitor cells
1998-01-01 Ghielmini, M; Colli, E; Bosshard, G; Zucchetti, M; D'Incalci, M; Geroni, C; Sessa, C
Interferon-beta can induce progesterone receptors in human endometrial adenocarcinoma
1996-01-01 Codegoni, Am; Landoni, F; Lomonico, S; Losa, G; Mangioni, C; Taverna, M; Lucchini, V; D'Incalci, M
High-performance liquid chromatographic assay for the determination of the novel taxane derivative IDN5109 in mouse plasma
1999-01-01 Colombo, T; Frapolli, R; Bombardelli, E; Morazzoni, P; Riva, A; D'Incalci, M; Zucchetti, M
Immediate Cooling Does Not Prevent the Ex Vivo Hydrolysis of L-Asparagine by Asparaginase
2014-01-01 Lanvers-Kaminsky, C; Westhoff, Ps; D'Incalci, M; Zucchetti, M; Boos, J
Quantitative Assessment of the Complex Dynamics of G(1), S, and G(2)-M Checkpoint Activities
2009-01-01 Ubezio, P; Lupi, M; Branduardi, D; Cappella, P; Cavallini, E; Colombo, V; Matera, G; Natoli, C; Tomasoni, D; D'Incalci, M
Patterns of tumor response to trabectedin (ET743) in myxoid liposarcomas
2006-01-01 Grosso, F; Demetri, Gd; Blay, Jy; Judson, I; Le Cesne, A; Spreafico, C; Jimeno, J; Pilotti, S; D'Incalci, M; Casali, Pg
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF 4'-DEMETHYL-EPIPODOPHYLLOTOXIN-9-(4,6-O-ETHYLIDENE BETA-D-GLUCOPYRANOSIDE) (VP 16-213) IN HUMAN-PLASMA
1981-01-01 Farina, P; Marzillo, G; D'Incalci, M
Flow cytometric analysis of cell cycle phase perturbations induced by Thiocoraline, a nem marine-derived anticancer compound
1997-01-01 Bergamaschi, D; Faretta, M; Ronzoni, S; Taverna, S; Defeudis, P; Bonfanti, M; Guidi, G; Faircloth, M; Jimeno, J; D'Incalci, M; Erba, E
Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib
2013-01-01 Zucchetti, M; Bonezzi, K; Frapolli, R; Sala, F; Borsotti, P; Zangarini, M; Cvitkovic, E; Noel, K; Ubezio, P; Giavazzi, R; D'Incalci, M; Taraboletti, G
Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies - Editorial comment
2002-01-01 D'Incalci, M
Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profiles
2014-01-01 Calura, E; Martini, P; Sales, G; Beltrame, L; Chiorino, G; D'Incalci, M; Marchini, S; Romualdi, C
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis | 1-gen-2017 | Zanotti, L; Romani, C; Tassone, L; Todeschini, P; Tassi, Ra; Bandiera, E; Damia, G; Ricci, F; Ardighieri, L; Calza, S; Marchini, S; Beltrame, L; Tognon, G; D'Incalci, M; Pecorelli, S; Sartori, E; Odicino, F; Ravaggi, A; Bignotti, E | |
| RHPS4 telomere-interactive molecule: An active antitumoral agent with a high therapeutic index and a favorable integration with camptothecin in preclinical models of solid tumors | 1-gen-2007 | Leonetti, C; Scarsella, M; Rizzo, A; Salvati, E; D'Incalci, M; Stevens, Mfg; Stoppacciaro, A; Stoppacciaro, A; Gilson, E; Zupi, G; Biroccio, A | |
| Selective effects of the anticancer drug Yondelis (ET-743) on cell-cycle promoters | 1-gen-2005 | Minuzzo, M; Ceribelli, M; Pitarque-Marti, Ma; Borrelli, S; Erba, E; Disilvio, A; D'Incalci, M; Mantovani, R | |
| Fsn0503h antibody-mediated blockade of cathepsin S as a potential therapeutic strategy for the treatment of solid tumors | 1-gen-2015 | Vazquez, R; Astorgues-Xerri, L; Bekradda, M; Gormley, J; Buick, R; Kerr, P; Cvitkovic, E; Raymond, E; D'Incalci, M; Frapolli, R; Riveiro, Me | |
| A Review of Trabectedin (ET-743): A Unique Mechanism of Action | 1-gen-2010 | D'Incalci, M; Galmarini, Cm | |
| In vitro and in vivo characterisation of low-resistant mouse reticulosarcoma (M5076) sublines obtained after pulse and continuous exposure to cisplatin | 1-gen-1996 | Belvedere, G; Imperatori, L; Damia, G; Tagliabue, G; Meijer, C; Devries, Ege; D'Incalci, M | |
| The atypical retinoid ST1926 acts as a strong pro-apoptotic agent in human neuroblastoma | 1-gen-2005 | Di Francesco, Am; Meco, D; Barone, G; Torella, A; Pisano, C; Vesci, L; Carminati, P; D'Incalci, M; Riccardi, R | |
| Synthesis of Fluorescent PMMA-Based Nanoparticles | 1-gen-2013 | Dossi, M; Ferrari, R; Dragoni, L; Martignoni, C; Gaetani, P; D'Incalci, M; Morbidelli, M; Moscatelli, D | |
| Differences in cyclin B1 expression in cells blocked in the G2M phase after treatment with anticancer agent. New three-parametric flow cytometric analysis | 1-gen-1997 | Faretta, M; Bergamaschi, D; Ronzoni, S; D'Incalci, M; Erba, E | |
| Evaluation of the hematotoxic potential of methoxymorpholinyl-doxorubicin (MMDX) metabolites in patients plasma by clonogenic assays on hemopoietic progenitor cells | 1-gen-1998 | Ghielmini, M; Colli, E; Bosshard, G; Zucchetti, M; D'Incalci, M; Geroni, C; Sessa, C | |
| Interferon-beta can induce progesterone receptors in human endometrial adenocarcinoma | 1-gen-1996 | Codegoni, Am; Landoni, F; Lomonico, S; Losa, G; Mangioni, C; Taverna, M; Lucchini, V; D'Incalci, M | |
| High-performance liquid chromatographic assay for the determination of the novel taxane derivative IDN5109 in mouse plasma | 1-gen-1999 | Colombo, T; Frapolli, R; Bombardelli, E; Morazzoni, P; Riva, A; D'Incalci, M; Zucchetti, M | |
| Immediate Cooling Does Not Prevent the Ex Vivo Hydrolysis of L-Asparagine by Asparaginase | 1-gen-2014 | Lanvers-Kaminsky, C; Westhoff, Ps; D'Incalci, M; Zucchetti, M; Boos, J | |
| Quantitative Assessment of the Complex Dynamics of G(1), S, and G(2)-M Checkpoint Activities | 1-gen-2009 | Ubezio, P; Lupi, M; Branduardi, D; Cappella, P; Cavallini, E; Colombo, V; Matera, G; Natoli, C; Tomasoni, D; D'Incalci, M | |
| Patterns of tumor response to trabectedin (ET743) in myxoid liposarcomas | 1-gen-2006 | Grosso, F; Demetri, Gd; Blay, Jy; Judson, I; Le Cesne, A; Spreafico, C; Jimeno, J; Pilotti, S; D'Incalci, M; Casali, Pg | |
| HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY DETERMINATION OF 4'-DEMETHYL-EPIPODOPHYLLOTOXIN-9-(4,6-O-ETHYLIDENE BETA-D-GLUCOPYRANOSIDE) (VP 16-213) IN HUMAN-PLASMA | 1-gen-1981 | Farina, P; Marzillo, G; D'Incalci, M | |
| Flow cytometric analysis of cell cycle phase perturbations induced by Thiocoraline, a nem marine-derived anticancer compound | 1-gen-1997 | Bergamaschi, D; Faretta, M; Ronzoni, S; Taverna, S; Defeudis, P; Bonfanti, M; Guidi, G; Faircloth, M; Jimeno, J; D'Incalci, M; Erba, E | |
| Pharmacokinetics and antineoplastic activity of galectin-1-targeting OTX008 in combination with sunitinib | 1-gen-2013 | Zucchetti, M; Bonezzi, K; Frapolli, R; Sala, F; Borsotti, P; Zangarini, M; Cvitkovic, E; Noel, K; Ubezio, P; Giavazzi, R; D'Incalci, M; Taraboletti, G | |
| Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies - Editorial comment | 1-gen-2002 | D'Incalci, M | |
| Wiring miRNAs to pathways: a topological approach to integrate miRNA and mRNA expression profiles | 1-gen-2014 | Calura, E; Martini, P; Sales, G; Beltrame, L; Chiorino, G; D'Incalci, M; Marchini, S; Romualdi, C |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891